Filing Details

Accession Number:
0001209191-22-011361
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-18 17:01:21
Reporting Period:
2022-02-16
Accepted Time:
2022-02-18 17:01:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325710 L Matthew Sherman C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-16 984 $9.05 76,790 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was to cover tax liabilities in the vesting of restricted stock.